These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 14739767)

  • 21. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc Deficiency Promoted Fibrosis via ROS and TIMP/MMPs in the Myocardium of Mice.
    Cao JW; Duan SY; Zhang HX; Chen Y; Guo M
    Biol Trace Elem Res; 2020 Jul; 196(1):145-152. PubMed ID: 31625053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure.
    Mishra PK; Tyagi N; Sen U; Givvimani S; Tyagi SC
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H451-6. PubMed ID: 19933416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rescue of proinflammatory cytokine-inhibited chondrogenesis by the antiarthritic effect of melatonin in synovium mesenchymal stem cells via suppression of reactive oxygen species and matrix metalloproteinases.
    Liu X; Xu Y; Chen S; Tan Z; Xiong K; Li Y; Ye Y; Luo ZP; He F; Gong Y
    Free Radic Biol Med; 2014 Mar; 68():234-46. PubMed ID: 24374373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of intracellular matrix metalloproteinase-2 by reactive oxygen-nitrogen species: Consequences and therapeutic strategies in the heart.
    Jacob-Ferreira AL; Schulz R
    Arch Biochem Biophys; 2013 Dec; 540(1-2):82-93. PubMed ID: 24103691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts.
    Siwik DA; Pagano PJ; Colucci WS
    Am J Physiol Cell Physiol; 2001 Jan; 280(1):C53-60. PubMed ID: 11121376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model.
    Mori S; Gibson G; McTiernan CF
    J Card Fail; 2006 May; 12(4):314-25. PubMed ID: 16679266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction.
    Gao CQ; Sawicki G; Suarez-Pinzon WL; Csont T; Wozniak M; Ferdinandy P; Schulz R
    Cardiovasc Res; 2003 Feb; 57(2):426-33. PubMed ID: 12566115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
    Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
    Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts.
    Tummalapalli CM; Heath BJ; Tyagi SC
    J Cell Biochem; 2001; 80(4):512-21. PubMed ID: 11169735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
    Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
    Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms.
    McCormick ML; Gavrila D; Weintraub NL
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):461-9. PubMed ID: 17218601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac matrix: a clue for future therapy.
    Mishra PK; Givvimani S; Chavali V; Tyagi SC
    Biochim Biophys Acta; 2013 Dec; 1832(12):2271-6. PubMed ID: 24055000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha.
    Nguyen HX; O'Barr TJ; Anderson AJ
    J Neurochem; 2007 Aug; 102(3):900-12. PubMed ID: 17561941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoteichoic acid isolated from Lactobacillus plantarum down-regulates UV-induced MMP-1 expression and up-regulates type I procollagen through the inhibition of reactive oxygen species generation.
    Hong YF; Lee Hy; Jung BJ; Jang S; Chung DK; Kim H
    Mol Immunol; 2015 Oct; 67(2 Pt B):248-55. PubMed ID: 26059754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection.
    Vanhoutte D; van Almen GC; Van Aelst LN; Van Cleemput J; Droogné W; Jin Y; Van de Werf F; Carmeliet P; Vanhaecke J; Papageorgiou AP; Heymans S
    Eur Heart J; 2013 Jul; 34(25):1930-41. PubMed ID: 23139380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
    Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
    Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.